Martin de Kort

The modified base J is the target for a nove lDNA‐binding protein in kinetoplastid protozoans

Mike Cross, Rudo Kieft, Robert Sabatini et al. · The EMBO Journal · 1999 · 89 citations · Full text

Life Sciences, Biology, Molecular Biology +3

Synthesis of Potent Agonists of the <scp>d</scp>-<i>m</i><i>yo</i>-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A

Martin de Kort, Vanessa Correa, A. Rob P.M. Valentijn et al. · Journal of Medicinal Chemistry · 2000 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +12

Development of a novel ionic support and its application in the ionic liquid phase assisted synthesis of a potent antithrombotic

Martin de Kort, Adriaan W. Tuin, Suzanne M. Kuiper et al. · Tetrahedron Letters · 2004 · 47 citations

Pharmacy, Medicinal Chemistry, Inorganic Chemistry +7

Drug repurposing for rare: progress and opportunities for the rare disease community

Anneliene Hechtelt Jonker, Daniel O’Connor, Maria Cavaller-Bellaubi et al. · Frontiers in Medicine · 2024 · 45 citations · Full text

Pharmacy, Health Informatics, Pharmacology +13

Synthesis of Oligodeoxynucleotides Containing 5-(β-D-Glucopyranosyloxymethyl)-2′-deoxyuridine, a Modified Nucleoside in the DNA ofTrypanosoma Brucei

Martin de Kort, Edwin Ebrahimi, Eric R. Wijsman et al. · European Journal of Organic Chemistry · 1999 · 31 citations

Pharmacy, Biochemistry, Molecular Biology +16